Our Pricing

What Is Mounjaro and How Can Stroud Residents Access It Online?

Published: 4 October 2026

Residents searching for Mounjaro Stroud now have convenient access to this MHRA-licensed tirzepatide weight loss injection through Cured Pharmacy's online prescription service. As a fully registered UK pharmacy (GPhC 9012511), we connect Stroud patients with experienced prescribers who assess eligibility for Mounjaro in under three minutes, ensuring safe, discreet delivery to your door. This guide explains how Mounjaro works, who qualifies, and how Stroud residents can begin treatment from £124.99.

Understanding Mounjaro Stroud Availability and Online Prescription Access

Mounjaro Stroud enquiries have increased significantly as more patients seek alternatives to in-person consultations at traditional pharmacies. Mounjaro (tirzepatide) is a once-weekly injectable prescription medicine licensed by the MHRA for weight management in adults with a BMI of 30 or above, or 27 or above with weight-related health conditions such as type 2 diabetes or hypertension[1]. Unlike older weight loss treatments, tirzepatide works as a dual GIP and GLP-1 receptor agonist, targeting two key hormonal pathways that regulate appetite and blood sugar control.

For Stroud residents, accessing Mounjaro through Cured Pharmacy eliminates the need for multiple GP appointments or pharmacy visits. Our UK-registered clinical team reviews your medical history, current medications, and weight loss goals through a secure online consultation. If approved, your prescription is dispensed by our superintendent pharmacist Tarun Kumar (GPhC 2233073) and delivered discreetly to your Stroud address within 24-48 hours. All Mounjaro supplied is genuine, UK-licensed medicine sourced directly from authorised wholesalers, ensuring full traceability and safety.

How Mounjaro Works for Stroud Patients Seeking Weight Loss

Mounjaro Stroud patients benefit from tirzepatide's unique dual-action mechanism, which has demonstrated superior weight loss outcomes compared to single-hormone therapies in clinical trials. The SURPASS-2 trial showed that participants taking tirzepatide 15mg lost an average of 12.4kg over 40 weeks, compared to 6.2kg with semaglutide 1mg[2]. Tirzepatide activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, leading to reduced appetite, slower gastric emptying, and improved insulin sensitivity.

Patients in Stroud starting Mounjaro typically begin with a 2.5mg dose for four weeks to minimise gastrointestinal side effects, then escalate gradually to 5mg, 7.5mg, 10mg, 12.5mg, or the maximum 15mg dose based on tolerance and weight loss progress. Each injection is administered subcutaneously once weekly using the pre-filled KwikPen device, which requires no assembly or dose measurement. Our clinical team provides detailed injection technique guidance and ongoing support throughout your treatment journey, with regular follow-up assessments to monitor efficacy and safety.

Expected Weight Loss Results with Mounjaro in Stroud

Clinical trial data provides realistic expectations for Mounjaro Stroud patients. The SURMOUNT-1 trial enrolled 2,539 adults without diabetes and demonstrated that participants taking tirzepatide 15mg achieved an average weight reduction of 20.9% from baseline over 72 weeks, compared to 3.1% with placebo[3]. Approximately 91% of participants on the highest dose achieved at least 5% weight loss, while 57% achieved 20% or greater weight loss. Individual results vary based on starting weight, adherence to treatment, dietary modifications, and physical activity levels. Our prescribers emphasise that Mounjaro is most effective when combined with a reduced-calorie diet and increased physical activity, as recommended by NICE guidelines for weight management interventions.

Mounjaro Stroud Pricing and How to Save £10 on Your First Order

Mounjaro Stroud pricing at Cured Pharmacy starts from £124.99 per four-week supply, with transparent costs displayed before you begin your consultation. We guarantee the lowest UK prices for genuine, licensed Mounjaro, with no hidden fees or subscription traps. New patients can Save £20 on their first order using code Weightlossnew at checkout, reducing the initial cost to £124.99. This upfront pricing model ensures Stroud residents know exactly what they'll pay before committing to treatment.

Your Mounjaro prescription includes the complete KwikPen device with four pre-filled injections (one month's supply), plus free delivery to any Stroud address. Follow-up prescriptions are processed seamlessly through your patient account, with automatic reminders to reorder before your supply runs out. We accept all major payment methods and offer flexible payment options to make weight loss treatment accessible. Unlike some providers, we never charge consultation fees separately—the price you see includes the full clinical assessment, prescription, medication, and delivery.

Who Qualifies for Mounjaro Stroud Prescriptions and Eligibility Criteria

Mounjaro Stroud prescriptions are issued only to patients who meet strict clinical eligibility criteria established by the MHRA and NICE. You must be aged 18 or over with a BMI of 30 kg/m² or above (classified as obese), or a BMI of 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease[4]. Our prescribers also assess your weight loss history, previous attempts with lifestyle interventions, current medications, and any contraindications to tirzepatide therapy.

Mounjaro is not suitable for everyone. Stroud patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 cannot use tirzepatide due to thyroid C-cell tumour risk observed in animal studies. Pregnant or breastfeeding women, individuals with severe gastrointestinal disease, and those with a history of pancreatitis require careful evaluation. Our online assessment captures your complete medical history to ensure safe prescribing, and our clinical team is available by phone (+44 116 4646009) if you have questions about eligibility before starting your consultation.

Medical Conditions That May Affect Mounjaro Stroud Suitability

Certain medical conditions require additional consideration when prescribing Mounjaro to Stroud patients. If you have diabetic retinopathy, your prescriber may recommend closer ophthalmological monitoring, as rapid glycaemic improvement has been associated with temporary worsening of retinopathy in some patients. Individuals with renal impairment can generally use tirzepatide, but dose escalation may proceed more cautiously due to increased risk of dehydration from gastrointestinal side effects. If you're taking insulin or sulfonylureas, dose adjustments may be necessary to reduce hypoglycaemia risk when starting Mounjaro. Our clinical team reviews all concurrent medications during your assessment to identify potential drug interactions and optimise your treatment plan safely.

Common Side Effects of Mounjaro for Stroud Patients and Management Strategies

Mounjaro Stroud patients should be aware of common side effects, most of which are gastrointestinal and typically diminish as your body adjusts to treatment. In clinical trials, nausea occurred in 12-22% of participants (depending on dose), diarrhoea in 13-17%, vomiting in 6-10%, and constipation in 6-7%[2]. These effects are usually mild to moderate and most common during the first few weeks after starting treatment or increasing your dose. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can help manage these symptoms.

Serious side effects are rare but require immediate medical attention. Stroud patients should contact their GP or NHS 111 if they experience severe abdominal pain that doesn't resolve (possible pancreatitis), visual changes, signs of thyroid nodules such as a lump in the neck or persistent hoarseness, or symptoms of severe allergic reaction including facial swelling or difficulty breathing. Hypoglycaemia (low blood sugar) can occur if you're also taking insulin or sulfonylureas—symptoms include trembling, sweating, confusion, and rapid heartbeat. Our clinical team provides detailed side effect guidance with every prescription and remains available for advice throughout your Mounjaro treatment journey.

How to Order Mounjaro Stroud from Cured Pharmacy in Three Simple Steps

Ordering Mounjaro Stroud through Cured Pharmacy is straightforward and takes under five minutes. First, complete our secure online medical consultation by answering questions about your weight, height, medical history, current medications, and weight loss goals. This assessment is reviewed by a UK-registered prescriber (doctor or independent prescriber) who determines whether Mounjaro is clinically appropriate for you. If approved, your prescription is issued electronically and sent directly to our pharmacy team for dispensing.

Second, your Mounjaro prescription is prepared by our superintendent pharmacist and quality-checked to ensure you receive genuine, in-date medication stored under correct conditions. We use 100% discreet packaging with no external branding or indication of contents, protecting your privacy. Third, your order is dispatched via tracked courier for next-day delivery to your Stroud address (orders placed before 3pm Monday-Friday). You'll receive email and SMS tracking updates so you know exactly when to expect your delivery. If you have any questions during the process, our pharmacy team is available by phone or email to provide support.

Ongoing Support for Mounjaro Stroud Patients

Cured Pharmacy provides continuous clinical support for all Mounjaro Stroud patients throughout their weight loss journey. After your initial prescription, you'll receive follow-up assessments at regular intervals (typically every 12 weeks) to review your progress, adjust your dose if needed, and monitor for any side effects or complications. Our prescribers track your weight loss percentage, BMI changes, and improvements in weight-related comorbidities to ensure Mounjaro remains the most appropriate treatment option. If you're not achieving at least 5% weight loss after 16 weeks at the maximum tolerated dose, our clinical team will discuss alternative strategies or treatments. This ongoing care model ensures you receive personalised, evidence-based support rather than a one-size-fits-all approach to weight management.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 4 October 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 4 October 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & SURMOUNT-1 Investigators. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 4 October 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. [accessed 4 October 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 4 October 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 4 October 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 4 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.